European Journal of Clinical Investigation

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

European Journal of Clinical Investigation（EJCI）考虑从最复杂的基础分子科学到应用临床和转化研究以及跨广泛的亚专业的循证医学的任何原创贡献。EJCI 发表与人类生物学和疾病的遗传、分子、细胞或生理学基础有关的高质量研究报告，以及涉及疾病的流行、诊断、病程、治疗和预防的研究，主要对与人类直接相关的研究感兴趣，但也鼓励提交可靠的体外和动物研究。